Current location:Stellar Space news portal > entertainment
Chinese inhibitor drug candidate becomes first to enter phase
Stellar Space news portal2024-05-21 09:43:46【entertainment】7People have gathered around
IntroductionChinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chines
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
Address of this article:http://www.afischerphasedrives.com/news-37b599950.html
Very good!(758)
Related articles
- Jon Wysocki dead at 53: Staind drummer passes away
- California is rolling out free preschool. That hasn't solved challenges around child care
- Rachel Brosnahan and Melissa McCarthy suit up for opening night of Broadway musical Suffs in NYC
- U.S. stocks end mixed ahead of inflation data
- Dodgers acquire pitcher Yohan Ramírez from Mets for cash
- Dickey Betts, Allman Brothers Band co
- Nick Viall, 43, and Natalie Joy, 25, get real about struggles getting intimate as new parents
- Eiza Gonzales is radiant in behind
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East
- Joy Corrigan poses for playful shoot for new line of Alo athletic wear and shares behind
Popular articles
Recommended
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
RMB retains 4th spot as currency for global payments: SWIFT
Saudi Arabia extends voluntary cut of oil production
China activates emergency response to rain, snowstorms amid holiday traffic peak
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Elly De La Cruz slugs 3
Braves' Travis d'Arnaud hits first 3 HRs of season, including go
Phillies' Turnbull loses no
Links
- Terry Dubrow calls out Kelly Clarkson for 'Ozempic
- France coach Deschamps includes Kanté and Barcola in preliminary Euro 2024 squad
- Space tech expo convenes in California, showcasing latest in space industry
- Ron Washington makes first return to Texas as an opposing manager with fond memories
- Sarah Hyland LICKS her husband Wells Adams' tongue in loved
- Judge dismisses lawsuit by Georgia court candidate who sued to keep talking about abortion
- Wisconsin election officials fear voter confusion over 2 elections for same congressional seat
- Justice Dept. makes arrests in North Korean identity theft scheme involving thousands of IT workers
- A's acquire right
- UNC interim chancellor backs AD Bubba Cunningham after trustee criticism, audit push